| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/31/2009 | US7511149 Using ruthenium tetraoxide and alkali metal permanganate |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511066 Antithrombotic aromatic ethers |
| 03/31/2009 | US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 03/31/2009 | CA2458679C Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives |
| 03/31/2009 | CA2356121C Novel propargylether derivatives |
| 03/31/2009 | CA2307285C Agent for prophylaxis and treatment of glaucoma |
| 03/26/2009 | WO2009038112A1 Solid preparation comprising npyy5 receptor antagonist |
| 03/26/2009 | WO2009037413A1 Dimers of 5- [ (4-cyanophenyl) sulfinyl] -6-methyl-2-oxo-1- [3- (trifluoromethyl)phenyl] -1,2-dihydropyridine-3-carboxamide as inhibitors of human neutrophil elastase for treating respiratory diseases |
| 03/26/2009 | WO2009036996A2 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | WO2009036938A1 Substituted nicotinamide compounds and the use thereof in pharmaceutical products |
| 03/26/2009 | WO2009036901A1 Method for producing 2,2-difluoroethylamine derivatives by imine hydrogenation |
| 03/26/2009 | WO2009036900A1 Method for producing 2,2-difluoroethylamine derivatives by amide hydrogenation |
| 03/26/2009 | WO2009014267A3 Imidate compound and use thereof for pest control |
| 03/26/2009 | WO2008142542A3 Processes for preparing benzofuro [3, 2-c] pyridine- 9-carbaldehyde derivatives as novel intermediates for the synthesis of pde iv inhibitors |
| 03/26/2009 | WO2008032204A8 Substituted pyridylmethyl bicyclocarboxyamide compounds |
| 03/26/2009 | US20090082573 Methods For Preparation Of Pyridylamines |
| 03/26/2009 | US20090082568 Accelerated reduction of organic substances with boranes |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090079343 Organic electroluminescent device |
| 03/26/2009 | CA2700051A1 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | CA2699689A1 Substituted nicotinamide compounds and their use in medicaments |
| 03/25/2009 | EP2039684A1 Method for manufacturing 2,2-difluoroethylamine derivatives by imine hydrogenation |
| 03/25/2009 | EP2038272A2 Pyridinonyl pdk1 inhibitors |
| 03/25/2009 | EP2038257A1 N-oxides of diarylurea derivatives and their use as chk1 inhibitors for the treatment of cancer |
| 03/25/2009 | EP2038256A1 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ']-bipyridine and its use as a medicament |
| 03/25/2009 | EP2038253A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1641740B1 Method for producing an optically active nitro compound |
| 03/25/2009 | EP1432684B1 Pyridinic sulfonamide derivatives, method of production and use thereof |
| 03/25/2009 | CN101395136A New pyridin-3-amine derivatives |
| 03/25/2009 | CN101395135A New primary amines |
| 03/25/2009 | CN101395106A Dibenzoanthracene compound and organic light emitting device having the same |
| 03/25/2009 | CN101392007A Anti-tumor manganese complexes using mitochondria as target point and preparation and use thereof |
| 03/25/2009 | CN101391979A Unsymmetrical bis(imino)pyridines iron and cobalt complexes containing halogen, preparation method and use |
| 03/25/2009 | CN101391978A Novel synthetic method of HIV-1 protease inhibitor atazanavir |
| 03/25/2009 | CN100471846C Cyanoacrylate compounds and their application in pesticide |
| 03/25/2009 | CN100471843C Superhigh purity ionic liquid |
| 03/25/2009 | CN100471840C Novel process for the preparation of roflumilast |
| 03/25/2009 | CN100471839C 2-pyridinylethylbenzamide derivatives |
| 03/24/2009 | US7507860 Androgen modulators |
| 03/24/2009 | US7507836 Benzamide modulators of metabotropic glutamate receptors |
| 03/24/2009 | US7507830 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles |
| 03/24/2009 | US7507828 Such as quinoline-8-carboxylic acid [5-(2-mercapto-acetylamino)-pentyl]-amide; increasing sensitivity of cancer cells to radiotherapy cytotoxic effects; neurological diseases |
| 03/24/2009 | US7507817 Glaucome therapy; vision defects |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | CA2437501C Process for the manufacture of phenylacetic acid derivatives |
| 03/24/2009 | CA2342616C Method of treating a textile |
| 03/24/2009 | CA2176373C Farnesyl derivatives and pharmaceutical compositions containing them |
| 03/19/2009 | WO2009035949A2 Soluble epoxide hydrolase inhibitors |
| 03/19/2009 | WO2009035598A1 Deuterated pirfenidone |
| 03/19/2009 | WO2009035542A2 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 03/19/2009 | WO2009034976A1 Alkylsulfone derivative |
| 03/19/2009 | WO2009034390A1 Heterocyclic derivatives and their use in treating hepatitis c |
| 03/19/2009 | WO2009034308A2 Process for the preparation of a raf kinase inhibitor and intermediates for use in the process |
| 03/19/2009 | WO2009033703A1 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones |
| 03/19/2009 | WO2009033702A1 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| 03/19/2009 | WO2009033561A1 Substituted 6-phenylnicotinic acids and the use thereof |
| 03/19/2009 | WO2009018502A3 Process for the synthesis of diaminopyridine and related compounds |
| 03/19/2009 | WO2009002510A3 Crystalline polymorph of exemestane |
| 03/19/2009 | WO2009002489A3 Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin |
| 03/19/2009 | WO2008024415A3 Process for the synthesis of cmhtp and intermediates thereof |
| 03/19/2009 | US20090076271 Process for preparing intermediates of HMG-CoA reductase inhibitors |
| 03/19/2009 | US20090076097 Deuterium-enriched atazanavir |
| 03/19/2009 | US20090076096 2-Pyridinylcycloalkylbenzamide derivatives and their use as fungicides |
| 03/19/2009 | US20090076095 Deuterium-enriched nicorandil |
| 03/19/2009 | US20090076048 Deuterium-enriched xaliproden |
| 03/19/2009 | US20090076005 Kinase inhibitor compounds |
| 03/19/2009 | US20090075993 N-[3-(1 -piperidinyl)propoxy]-pyridin-1-oxide-3-carboxamidine ; increasing vaso-relaxation of a vessel associated with endothelial cells |
| 03/19/2009 | US20090075989 Non-steroidal progesterone receptor modulators |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090075975 Arylsulfonamides and uses related thereto |
| 03/19/2009 | US20090075968 CETP inhibitors |
| 03/19/2009 | US20090075952 Nitroderviatives as drugs for diseases having an inflammatory basis |
| 03/19/2009 | US20090075823 Process for preparing pyridinamines and novel polymorphs thereof |
| 03/19/2009 | US20090075819 Indanyl- and Tetrahydronaphtyl-amino-thiourea Compounds for Combating Animal Pests |
| 03/19/2009 | US20090074887 For control of phytopathogenic fungi; synergistic |
| 03/19/2009 | US20090074709 Methods, devices and systems for biocidal surface activity |
| 03/19/2009 | DE102007044277A1 Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln Substituted nicotinamide compounds and their use in medicaments |
| 03/19/2009 | CA2698929A1 1,3-disubstituted-4-phenyl-1h-pyridin-2-ones |
| 03/19/2009 | CA2698795A1 Process for the preparation of a raf kinase inhibitor and intermediates for use in the process |
| 03/19/2009 | CA2698471A1 Substituted 6-phenylnicotinic acids and the use thereof |
| 03/19/2009 | CA2698371A1 Alkylsulfone derivatives |
| 03/19/2009 | CA2697752A1 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 03/19/2009 | CA2697399A1 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| 03/18/2009 | EP2035401A2 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/18/2009 | EP2035383A2 Process for making solid triphenylboron-pyridine |
| 03/18/2009 | EP2035369A1 Therapeutic compounds |
| 03/18/2009 | EP2034993A2 Pyrazinones as cellular proliferation inhibitors |
| 03/18/2009 | EP1919850B1 Nitro substituted alpha-olefin synthesis catalysts |
| 03/18/2009 | EP1689380A4 Method for treating adamts-5-associated disease |
| 03/18/2009 | EP1615629B1 Peptide deformylase inhibitors |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | CN101389619A Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 03/18/2009 | CN101389607A Substituted arylsulfonamides as antiviral agents |
| 03/18/2009 | CN101389606A Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (CETP) |
| 03/18/2009 | CN101389597A Carbonates of fenicol antibiotics |
| 03/18/2009 | CN101386630A Organic electroluminescence device |
| 03/18/2009 | CN100469770C 5-substituted-pyrazine or -pyridine glucokinase activators |
| 03/18/2009 | CN100469768C Preparation method of hydrated sodium phenolate trichloropyridine |